Skip to main content

Table 1 Clinical baseline of 440 LUAD patients in TCGA cohort

From: Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma

Variables

TCGA-LUAD (n = 440)

Age (median [IQR])

66.00 [59.00, 72.75]

Gender (%)

 Female

235 (53.4)

 Male

205 (46.6)

Status (%)

 Dead

282 (64.1)

 Alive

158 (35.9)

Pathologic T (%)

 T1

152 (34.5)

 T2

231 (52.5)

 T3

39 (8.9)

 T4

16 (3.6)

 Tx

2 (0.5)

Pathologic N (%)

 N0

289 (65.8)

 N1

80 (18.2)

 N2

62 (14.1)

 N3

1 (0.2)

 Nx

7 (1.6)

Pathologic M (%)

 M0

278 (63.8)

 M1

19 (4.4)

 Mx

139 (31.9)

Tumor stage (%)

238 (54.7)

 I

238 (54.7)

 II

108 (24.8)

 III

70 (16.1)

 IV

19 (4.4)